Wikidata

(Q61902304)

English

Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101

clinical trial

In more languages

Statements

short name
SNAP101 (English)
0 references
title
Phase1 Randomized, Double-Blind, Placebo/Active-Controlled, SAD, 2-Way, Incomplete Block, 2-Period Crossover, Safety, Tolerability, PK/PD Study of 3 Doses INP105 (Olanzapine Delivered by I231 POD® Device) Nasal Spray in Healthy Volunteers (English)
0 references
country
Australia
0 references
start time
5 August 2018
0 references
end time
3 October 2018
0 references
number of participants
38
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61902304&oldid=2103841721"